Advertisement

Zimmer Biomet Holdings, Inc. ZBH

Set alert

Price alert · ZBH

All alert types
97.35 USD +2.83 +2.99%

At close · Nov 2

97.35 0.00 0.00%

After hours · Nov 2, 4:05 PM ET

Bid
97.29 × 200
Ask
97.37 × 200
94.50 Day range 97.35
79.12 52-week range 103.70
YTD
+8.26%
1 year
-3.19%
Open
95.09
Prev close
94.52
Mkt cap
18.57B
Vol
2.58M
Avg vol
2.08M
EPS
4.12
P/E
23.63
Div yield
1.02%
More statistics
Low
94.50
High
97.35
Forward P/E
10.75
Beta
0.47
Short ratio
3.64
Inst. own
111.30%
Dividend
0.96
Ex-div date
Sep 29, 2026
Earnings
Nov 4, 2026
50-d avg
94.85
200-d avg
91.63
1y target
106.90

3M chart

Chart tools
Interval

Events in this range
  • Aug 5, 2026Earnings: 2.07; estimate 2.01; surprise 2.99%
  • Aug 6, 2026Rating: Bernstein · Market Perform → Market Perform
  • Aug 6, 2026Rating: RBC Capital · Outperform → Outperform
  • Aug 7, 2026Rating: Truist Securities · Hold → Hold
  • Aug 10, 2026Rating: Canaccord Genuity · Hold → Hold
  • Sep 30, 2026Dividend: 0.24
  • Oct 7, 2026Rating: Barclays · — → Equal-Weight
  • Oct 22, 2026Rating: Argus Research · Buy → Buy
Signals (14)
NameDateAgo
SMA: BullishNov 2, 20267 hours ago
SMA: BearishOct 30, 20263 days ago
SMA: BullishOct 22, 20261 week ago
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BullishOct 15, 20262 weeks ago
MACD: Buy SignalOct 12, 20263 weeks ago
SMA: BearishSep 17, 20261 month ago
SMA: BearishSep 16, 20261 month ago
SMA: BullishSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BearishSep 4, 20261 month ago
MACD: Sell SignalAug 25, 20262 months ago

Key statistics

Market cap
18.56B
Enterprise value
25.17B
Trailing P/E
23.62
Forward P/E
10.75
PEG ratio
0.59
Price / sales
2.18
Price / book
1.47
EPS (TTM)
4.12
Beta
0.47
Dividend yield
1.02%
Payout ratio
23.30%
Profit margin
9.48%
Revenue (TTM)
8.51B
Revenue growth
4.80%
Free cash flow
1.07B
Total cash
464.50M
Total debt
7.60B
Return on equity
6.41%
Shares outstanding
190.74M
Short % of float
5.51%
50-day average
94.85
200-day average
91.63

Analyst view

Consensus: buy

Buy
Price target (mean) 106.90 +9.8% upside
Target (low)
93.00
Target (mean)
106.90
Target (high)
130.00
Ratings (0m) 27 8 buy · 19 hold · 0 sell
  • Strong buy2
  • Buy6
  • Hold19
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 1.88.

Earnings history

Financials — quick view

All financials
ZBH Revenue — quarterly 2.18B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ZBH Net income — quarterly 198.30M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ZBH EPS — quarterly 1.03
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ZBH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 20261.88———
Aug 5, 2026Jun 30, 20262.012.07+0.06+2.99%
Apr 28, 2026Mar 31, 20261.862.09+0.23+12.37%
Feb 10, 2026Dec 31, 20252.382.42+0.04+1.68%
Nov 5, 2025Sep 30, 20251.871.90+0.03+1.60%
Aug 7, 2025Jun 30, 20251.982.07+0.09+4.55%

Upgrades / downgrades

ZBH analyst upgrades and downgrades
DateFirmActionFromTo
Oct 22, 2026Argus ResearchreitBuyBuy
Oct 7, 2026Barclaysinit—Equal-Weight
Aug 10, 2026Canaccord GenuitymainHoldHold
Aug 7, 2026Truist SecuritiesmainHoldHold
Aug 6, 2026RBC CapitalmainOutperformOutperform
Aug 6, 2026BernsteinmainMarket PerformMarket Perform

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ZBH — it syncs with the Stock Master app.

Insider holders

ZBH insider holders
InsiderRelationLatest transactionDateShares held
BEZJAK MARKOfficerConversion of Exercise of derivative securityMar 5, 202513,134
ELLINGSON RACHEL H.OfficerConversion of Exercise of derivative securityFeb 19, 202511,906
NOOR JEHANZEBOfficerConversion of Exercise of derivative securityMar 31, 20265,151
PHIPPS CHAD FOfficerSaleSep 3, 202665,231
STELLATO PAUL AOfficerConversion of Exercise of derivative securityMar 5, 20265,582
TORNOS IVANChief Executive OfficerConversion of Exercise of derivative securityMar 5, 202683,191

Institution ownership

ZBH institution ownership
Holder% heldSharesValueReported
Dodge & Cox Inc.12.65%24,124,7352.35BJun 29, 2026
Blackrock Inc.8.19%15,614,8471.52BJun 29, 2026
Harris Associates L.P.6.68%12,738,0251.24BJun 29, 2026
Vanguard Capital Management LLC6.62%12,634,9371.23BJun 29, 2026
Capital International Investors6.39%12,183,6141.19BJun 29, 2026
State Street Corporation4.65%8,877,171864.02MJun 29, 2026

Fund ownership

ZBH fund ownership
Holder% heldSharesValueReported
Dodge & Cox Funds-Dodge & Cox Stock Fund8.15%15,549,9001.51BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.22%6,141,461597.75MJun 29, 2026
VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund3.08%5,867,350571.07MJul 30, 2026
HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark Fund2.95%5,621,292547.12MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.63%5,010,793487.70MJun 29, 2026
WASHINGTON MUTUAL INVESTORS FUND2.42%4,610,277448.72MSep 29, 2026
Advertisement